We are live on ! Find out more
Geode Capital Management

Geode Capital Management Portfolio holdings

AUM $1.61T
1-Year Est. Return 30.72%
 

Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.

This Fund
S&P 500
This Quarter Est. Return
+4.5%
1 Year Est. Return
+30.72%
3 Year Est. Return
+105.46%
5 Year Est. Return
+141.95%
10 Year Est. Return
+549.41%
AUM
$413B
AUM Growth
+$27.3B
Cap. Flow
+$13.5B
Cap. Flow %
3.28%
Top 10 Hldgs %
17.41%
Holding
4,308
New
177
Increased
3,043
Reduced
580
Closed
101

Top Buys

Rank Stock Value
1
DOW icon
Dow Inc
DOW
+$511M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$442M
3
MSFT icon
Microsoft
MSFT
+$392M
4
AMZN icon
Amazon
AMZN
+$348M
5
CTVA icon
Corteva
CTVA
+$288M

Sector Composition

Rank Sector Weight
1 Technology 18.3%
2 Financials 15.46%
3 Healthcare 13.81%
4 Consumer Discretionary 10.38%
5 Industrials 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CRNT icon
3901
Ceragon Networks
CRNT
$192M
$106K ﹤0.01%
36,506
-48,460
-57% -$159K
KUST
3902
Kustom Entertainment Inc
KUST
$683K
0
LSTA icon
3903
Lisata Therapeutics
LSTA
$9.82M
$106K ﹤0.01%
3,103
TTNP
3904
DELISTED
Titan Pharmaceuticals
TTNP
$105K ﹤0.01%
138
+43
+45% +$39.3K
SCPH
3905
DELISTED
scPharmaceuticals
SCPH
$104K ﹤0.01%
32,683
-22,360
-41% -$73.1K
WHWK
3906
Whitehawk Therapeutics
WHWK
$259M
$104K ﹤0.01%
7,660
FOMX
3907
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
$104K ﹤0.01%
43,737
+23,767
+119% +$71K
LIVE icon
3908
Live Ventures
LIVE
$30.7M
$103K ﹤0.01%
14,842
SAEX
3909
DELISTED
SAExploration Holdings, Inc.
SAEX
$103K ﹤0.01%
28,628
+6,136
+27% +$21.4K
SITO
3910
DELISTED
SITO MOBILE, LTD
SITO
$103K ﹤0.01%
131,211
PME
3911
DELISTED
Pingtan Marine Enterprise Ltd.
PME
$103K ﹤0.01%
37,129
PRPO icon
3912
Precipio
PRPO
$40.4M
$102K ﹤0.01%
+1,512
New +$155K
ADXS
3913
DELISTED
Advaxis Inc
ADXS
$102K ﹤0.01%
48,963
+32,734
+202% +$104K
BNBX
3914
DELISTED
BNB PLUS CORP
BNBX
0
ELMD icon
3915
Electromed
ELMD
$353M
$100K ﹤0.01%
18,483
GTIM icon
3916
Good Times Restaurants
GTIM
$15.5M
$100K ﹤0.01%
56,983
PLUR icon
3917
Pluri
PLUR
$19.9M
$100K ﹤0.01%
2,024
+657
+48% +$32.9K
ASLEW
3918
DELISTED
AerSale Corp Warrants
ASLEW
$100K ﹤0.01%
350,000
XIN
3919
DELISTED
Xinyuan Real Estate
XIN
$99K ﹤0.01%
+2,385
New +$107K
OIG
3920
DELISTED
Orbital Infrastructure Group, Inc. Common Stock
OIG
$99K ﹤0.01%
3,030
SLNO
3921
DELISTED
Soleno Therapeutics
SLNO
$98K ﹤0.01%
2,340
+404
+21% +$14K
CORV
3922
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
$98K ﹤0.01%
45,429
+11,631
+34% +$29.7K
DCOY
3923
Decoy Therapeutics
DCOY
$2.04M
0
VIRC icon
3924
Virco
VIRC
$93.6M
$95K ﹤0.01%
20,401
PHUN icon
3925
Phunware
PHUN
$41.7M
$94K ﹤0.01%
+608
New +$185K

Similar funds

Geode Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Geode Capital Management held 4,308 positions worth $413B, up 7.1% from $386B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Geode Capital Management deployed $13.5B of net new capital in Q2 2019, opening 177 new positions and adding to 3,043 existing holdings. Its largest new stake was Dow Inc: 9,682,103 shares worth $477M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was DuPont de Nemours, an estimated $419M trimmed.

  • Geode Capital Management's largest Q2 2019 buy was Dow Inc: 9,682,103 shares worth $477M.
  • Geode Capital Management added most to Alphabet (Google) Class A in Q2 2019, an estimated $442M increase.
  • Geode Capital Management's biggest Q2 2019 reduction was DuPont de Nemours, cutting an estimated $419M.
  • Geode Capital Management fully exited Ultimate Software Group Inc in Q2 2019, selling an estimated $109M.
  • Geode Capital Management's ten largest holdings make up 17% of its $413B portfolio in Q2 2019.
  • Geode Capital Management opened 177 new positions and closed 101 in Q2 2019.
  • Geode Capital Management's portfolio value rose 7.1% quarter-over-quarter to $413B.

Based on Geode Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.